Drug

Adenosine

Fast-on, fast-off AV-nodal blocker. Diagnostic for SVT, used to unmask dormant PV conduction, and to test accessory pathways.

Indication
Termination of AV-nodal–dependent SVT; dormant PV conduction testing; accessory pathway evaluation
Typical dose
6 mg rapid IV push, repeat 12 mg x1–2 if needed; central line doses reduced

Why we use it

Adenosine is an endogenous nucleoside that hyperpolarizes AV-nodal tissue via A1 receptors, producing a brief, profound block at the AV node and slowing of the sinus node. The block is dramatic and short. That short window is exactly what makes adenosine so useful — we can stop a re-entrant SVT, expose an underlying atrial rhythm, or watch for dormant conduction without committing to a long pharmacologic effect.

Indication in the lab

  • Terminating AV-nodal-dependent SVT (AVNRT, AVRT) — both diagnostic and therapeutic
  • Unmasking atrial flutter or atrial tachycardia hiding behind 2:1 conduction
  • PV reconnection testing after isolation — adenosine can transiently restore conduction across an incomplete line
  • Accessory pathway testing — pre-excitation behavior under AV block can localize and characterize pathways
  • Differential for wide-complex tachycardia in selected stable patients (use with care)

Dose and route

  • Standard peripheral push: 6 mg rapid IV, immediately followed by a 10–20 mL saline flush.
  • Repeat dose: 12 mg if the first dose doesn’t work; can give a second 12 mg.
  • Central line dose: halve it (start at 3 mg) — closer delivery means a bigger hit.
  • Pediatric dose: 0.1 mg/kg, then 0.2 mg/kg if needed.

Technique matters: use a stopcock with adenosine and the saline flush set up so the flush goes in within a second of the push. A slow push = no effect.

Onset and duration

  • Onset: 10–20 seconds (one circulation time).
  • Peak effect: a few seconds.
  • Total duration: under 30 seconds.

Monitoring

  • Continuous ECG with a printed strip or saved recording — review what happened during the pause
  • Continuous BP and SpO2
  • Pacing capability available (transcutaneous pads on, or temp wire in)
  • A second team member at the patient’s head to coach them through the symptoms

What the patient feels

Warn before the push:

  • “You’ll feel a wave of heat, maybe chest pressure or shortness of breath, and a strong sense that something is wrong. It lasts about 10 seconds and then it’s gone.”
  • Many patients say this is the worst part of the case. Brief but intense.

Side effects to watch for

  • Bronchospasm — caution or avoid in active asthma; theophylline and caffeine blunt the effect
  • Profound bradycardia or asystole — usually self-limited, but be ready to pace
  • Atrial fibrillation triggered by the push — short-lived in most, but a known complication
  • Hypotension — brief, almost always resolves with the half-life
  • Pre-excited AF — adenosine in WPW with AF can accelerate ventricular response via the accessory pathway. Avoid in this setting.

Cautions and interactions

  • Heart transplant recipients — denervated supersensitive hearts; reduce dose by ~75%
  • Dipyridamole — blocks reuptake, dramatically prolongs and intensifies effect
  • Carbamazepine — potentiates AV block
  • Methylxanthines (caffeine, theophylline) — antagonize; may need higher dose

Reversal

No specific reversal needed in practice — half-life is too short. If a prolonged pause occurs, transcutaneous or transvenous pacing bridges the gap. Aminophylline can theoretically antagonize but is rarely needed.

Common pitfalls

  • Pushing slowly — the drug is metabolized before it reaches the heart.
  • Not having the saline flush ready in the same syringe pathway.
  • Forgetting to save the strip — the diagnostic value lives in that 10-second window.
  • Giving full peripheral dose down a central line.

Last reviewed by Dr. Colombowala on May 22, 2026.

Not medical advice. This page is educational. Your situation may differ — discuss it with Dr. Colombowala or your treating physician before making decisions.